NASDAQ

TScan Therapeutics, Inc. (TCRX)

♥ 565 Thanks from members

Live price chart, market sentiment, and community perspectives for TScan Therapeutics, Inc. (NASDAQ: TCRX).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Paul KeungFounder: David BaltimoreLeadership: Hagen Munk (CEO)Leadership: Debbie McPherson (CBO)Leadership: Jonathan Terrett (CSO)Holder: SanofiHolder: The Vanguard GroupHolder: BlackRock Inc.Holder: RA Capital ManagementImmTCR platformTCR-T cell therapiesPipeline for cancer and autoimmune diseases#TScan Therapeutics#TCRX#T-cell therapy#immunotherapy biotech#cancer pipeline